Triple Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents

Patients with metastatic triple negative breast cancer (TNBC) have poor treatment outcomes. We reviewed the electronic records of consecutive patients with metastatic TNBC treated in phase I clinic at MD Anderson between August 2005 and May 2012. One hundred and six patients received at least 1 phas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer Ther
Autors principals: Ganesan, Prasanth, Moulder, Stacy, Lee, J. Jack, Janku, Filip, Valero, Vicente, Zinner, Ralph G., Naing, Aung, Fu, Siqing, Tsimberidou, Apostolia M., Hong, David, Stephen, Bettzy, Stephens, Philip, Yelensky, Roman, Meric-Bernstam, Funda, Kurzrock, Razelle, Wheler, Jennifer J.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258414/
https://ncbi.nlm.nih.gov/pubmed/25253784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-14-0358
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars